Effect of chromium dinicocysteinate supplementation on circulating levels of insulin, <scp>TNF</scp>‐α, oxidative stress, and insulin resistance in type 2 diabetic subjects: Randomized, double‐blind, placebo‐controlled study

Sushil K. Jain, Gunjan Kahlon, Lester Morehead, Richa Dhawan, Benjamin J. Lieblong, Tommie Stapleton, Gloria Caldito, Robert D. Hoeldtke, Steven N. Levine, Pat F. Bass

Molecular Nutrition & Food Research · 2012 · 66 citations · 21 references

DOIFull text

Open access

Abstract

CDNC supplementation lowers insulin resistance by reducing blood levels of TNF-α, insulin, and oxidative stress in type 2 diabetic subjects. Therefore, CDNC supplementation has potential as an adjunct therapy for individuals with type 2 diabetes.

References

21